Bioteque Corporation (TPEX:4107)

Market Cap	8.32B
Revenue (ttm)	2.09B
Net Income (ttm)	537.11M
Shares Out	69.30M
EPS (ttm)	7.71
PE Ratio	15.56
Forward PE	n/a
Dividend	5.00 (4.29%)
Ex-Dividend Date	Jul 28, 2025

Volume	209,791
Average Volume	98,815
Open	116.50
Previous Close	116.50
Day's Range	116.50 - 121.50
52-Week Range	101.00 - 147.50
Beta	0.10
RSI	53.64
Earnings Date	Aug 8, 2025

About Bioteque

Bioteque Corporation manufactures and sells medical devices in Asia, South America, North America, and internationally. The company provides medical disposables for use in hemodialysis access, endovascular treatment, and other fields. It offers dialysis products, including hemodialysis bloodlines, A.V.F. needles, and hemodialysis cathers; interventional radiology products, such as pigtail drainage catheter sets, introducer sets, connecting tubes, drainage bags, and radiopaque dilators; urology products comprising ureteral stent sets and urine c...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1991
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4107

Financial Performance

In 2024, Bioteque's revenue was 2.07 billion, an increase of 6.58% compared to the previous year's 1.94 billion. Earnings were 528.26 million, an increase of 16.73%.